Command Palette

Search for a command to run...

Parnax Lab Ltd.
132.95(-2.49%)
1W: -2.15%

Peers

Snapshot Summary

In the Pharmaceuticals & Drugs sector, Parnax Lab Ltd. shows underwhelming performance with negative revenue growth and a high PE ratio compared to its peers. However, peers like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. demonstrate strong profitability and growth metrics, positioning them as sector leaders. Parnax Lab should focus on improving growth and profitability to align with industry standards.

  • • Parnax Lab has negative revenue growth and high PE, indicating underperformance.
  • • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. lead in profitability metrics and growth.
  • • Divi's Laboratories, while highly valued, shows weak growth, making it a potential value trap.
  • • Cipla Ltd.: Strong revenue growth (13.28% YoY) and the lowest PE ratio (23.73) among peers.
  • • Dr. Reddy's Laboratories Ltd.: Excellent profitability with a ROE of 21.76% and a low PE of 15.50.
  • • Mankind Pharma Ltd.: Highest revenue growth (18.12% YoY) and solid ROE (23.15%).
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Parnax Lab Ltd.₹128.30₹147.36Cr105.6313.61%0.99
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02
Explore
Watchlists
Chat
Portfolio